{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T20:22:07Z","timestamp":1794946927905,"version":"4.9.1"},"reference-count":35,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T00:00:00Z","timestamp":1578960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Special Public Welfare Industry Research of National Health and Family Planning Commission of China","award":["201402010"],"award-info":[{"award-number":["201402010"]}]},{"name":"Applied Basic Research project of Shanxi province","award":["201601D011086"],"award-info":[{"award-number":["201601D011086"]}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer Medicine"],"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The association between vaginal pH and the risk of cervical intraepithelial neoplasia (CIN) is unclear. We evaluated the dose\u2010response relationship between vaginal pH and CIN risk, as well as the combined influence of vaginal pH and high\u2010risk human papillomavirus (hrHPV) on the risk of CIN and the mediation effects of hrHPV infection on vaginal pH level and the development of CIN. We investigated 2304 women in Shanxi, China. The dose\u2010response relationship between vaginal pH and CIN risk was assessed using categoric and spline analyses. We established interaction and mediation models to determine the correlation between pH and hrHPV in the development of CIN. After adjusting covariates, a positive association was observed between hrHPV infection and the development of CIN [OR (95% CI)\u00a0=\u00a04.75 (3.52\u20106.40) for CIN2+; OR (95% CI)\u00a0=\u00a07.30 (4.10\u201013.00) for CIN3+], while a negative correlation was showed between vaginal pH level and CIN3+ [OR (95% CI)\u00a0=\u00a01.04 (0.59\u20101.84); high vs low: OR (95% CI)\u00a0=\u00a00.32 (0.15\u20100.69), <jats:italic>P<\/jats:italic>\u00a0=\u00a0.002]. The highest risk of CIN (5.24 of CIN2+ and 5.80 of CIN3+) were observed when hrHPV infection was combined with middle vaginal pH (4.6\u20105.0). A significant mediation effect of hrHPV infection was observed in the association between vaginal pH level with CIN2+ (<jats:italic>P<\/jats:italic>\u00a0=\u00a0.002) and CIN3+ (<jats:italic>P<\/jats:italic>\u00a0=\u00a0.004). In conclusion, abnormal vaginal pH significantly induced the risk of high\u2010stage CIN in Chinese women infected with hrHPV. Therefore, maintaining normal vaginal pH levels may reduce the risk of CIN.<\/jats:p>","DOI":"10.1002\/cam4.2845","type":"journal-article","created":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T09:34:04Z","timestamp":1578994444000},"page":"1890-1902","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["A population\u2010based study of age\u2010related associations between vaginal pH and the development of cervical intraepithelial neoplasia"],"prefix":"10.1002","volume":"9","author":[{"given":"Peng","family":"Teng","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology Second Hospital of Shanxi Medical University Taiyuan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5007-9787","authenticated-orcid":false,"given":"Min","family":"Hao","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Second Hospital of Shanxi Medical University Taiyuan China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,1,14]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1604113"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(19)30482-6"},{"issue":"4","key":"e_1_2_10_4_1","first-page":"346","article-title":"Analysis of the reported data of national rural cervical cancer screening project from 2012 to 2013, China","volume":"50","author":"Luo XM","year":"2016","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"issue":"3","key":"e_1_2_10_5_1","first-page":"260","article-title":"The impact of five\u2010year Chinese rural area cervical cancer screening program on screening rate","volume":"52","author":"Bao HL","year":"2018","journal-title":"Zhonghua yu fang yi xue za zhi"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21338"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.05.089"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12307-011-0066-7"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61416-0"},{"issue":"4","key":"e_1_2_10_10_1","first-page":"95","article-title":"Aspectos epidemiol\u00f3gicos da infec\u00e7\u00e3o pelo papilomav\u00edrus humano","volume":"107","author":"Murta E","year":"1997","journal-title":"Jornal Brasileiro De Ginecologia"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910520514"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/LGT.0000000000000343"},{"issue":"3","key":"e_1_2_10_13_1","first-page":"267","article-title":"Distribution characteristics of microorganisms in the vagina of patients with cervical cancer","volume":"40","author":"Cai\u2010Hong LU","year":"2011","journal-title":"J China Med Univ"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2011.06.001"},{"issue":"54","key":"e_1_2_10_15_1","first-page":"1914","article-title":"Chemopreventive effect of a probiotic preparation on the development of preneoplastic and neoplastic colonic lesions: an experimental study","volume":"50","author":"Marotta F","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-1605(02)00477-4"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-12-33"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2010.07.010"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.01936"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/13697130500087016"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2010.08.003"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(99)70595-8"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-31248-4_6"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00181"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045201"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-10-0212"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-016-0203-0"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2016.07.004"},{"issue":"1","key":"e_1_2_10_29_1","first-page":"S1","article-title":"The epidemiology of genital human papillomavirus infection","volume":"24","author":"Trottier H","year":"2006","journal-title":"Vaccine"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25396"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22527"},{"issue":"12","key":"e_1_2_10_32_1","first-page":"1351","article-title":"Multi\u2010center cross\u2010sectional study on type\u2010specific human papillomavirus infection among Chinese women","volume":"36","author":"Zhao Y","year":"2015","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.7150\/jca.14971"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.7150\/jca.25614"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-2599"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/LGT.0000000000000354"}],"container-title":["Cancer Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcam4.2845","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cam4.2845","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cam4.2845","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cam4.2845","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T14:46:13Z","timestamp":1728571573000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cam4.2845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,14]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["10.1002\/cam4.2845"],"URL":"https:\/\/doi.org\/10.1002\/cam4.2845","archive":["Portico"],"relation":{},"ISSN":["2045-7634","2045-7634"],"issn-type":[{"value":"2045-7634","type":"print"},{"value":"2045-7634","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,14]]},"assertion":[{"value":"2019-10-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}